Tibet Weixinkang Medicine Co., Ltd.

SSE:603676.SS

11.51 (CNY) • At close June 9, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202420232022202120202019201820172016201520142013
Revenue 1,300.2351,322.6491,398.5431,033.623715.667740.963746.325420.382426.361440.234390.795342.298
Cost of Revenue 594.936651.244662.875500.401384.116393.621400.144177.735160.987161.212125.174115.628
Gross Profit 705.299671.405735.668533.221331.551347.342346.181242.647265.374279.022265.621226.67
Gross Profit Ratio 0.5420.5080.5260.5160.4630.4690.4640.5770.6220.6340.680.662
Reseach & Development Expenses 116.01112.8272.45338.01923.19529.13824.44325.01527.17830.92123.2430
General & Administrative Expenses 33.47842.2674.14541.05513.48111.29313.57112.73517.53620.41718.89668.096
Selling & Marketing Expenses 177.862255.417312.189275.506191.258202.151199.69879.69870.50172.2165.23953.741
SG&A 211.34297.677386.333316.561204.739213.444213.26992.43388.03692.62784.135121.837
Other Expenses 97.092-18.095109.69681.25658.29360.0091.09926.73714.0786.09410.69711.352
Operating Expenses 424.443497.138568.483435.836286.227302.591290.416157.876153.91158.727140.109126.334
Operating Income 280.856174.963162.602102.28544.66855.22276.64488.67113.319120.774127.227100.828
Operating Income Ratio 0.2160.1320.1160.0990.0620.0750.1030.2110.2660.2740.3260.295
Total Other Income Expenses Net -4.25340.87519.75311.94310.33610.7111.09926.73713.5675.3819.8588.095
Income Before Tax 276.603215.838182.355114.22869.6265.93377.743115.408126.886126.155137.085108.923
Income Before Tax Ratio 0.2130.1630.130.1110.0970.0890.1040.2750.2980.2870.3510.318
Income Tax Expense 30.4341.8215.39718.31711.19510.2554.30713.8211.97113.12920.88421.18
Net Income 246.169214.017176.95895.91158.42555.67873.436101.587114.916112.935106.73682.95
Net Income Ratio 0.1890.1620.1270.0930.0820.0750.0980.2420.270.2570.2730.242
EPS 0.570.50.410.230.140.130.170.260.320.6250.830.46
EPS Diluted 0.570.50.410.230.140.130.170.260.320.6250.830.46
EBITDA 329.719266.606225.689152.43868.51894.168100.902134.669131.526132.421136.442107.309
EBITDA Ratio 0.2540.2020.1610.1470.0960.1270.1350.320.3080.3010.3490.313